Brazil's AIDS controversy: Antiretroviral drugs, breaking patents, and compulsory licensing

Food and Drug Law Journal

Volumn 60, Issue 3, 2005, Pages

  Quintanilha Marques, Ubirajara Regis ^a   Santos Guimarães, Valeska ^a   Sternberg, Caitlin ^a,b  

^a Vicente Nogueira Advogados ^*  (Brazil)

^b UNIVERSITY OF SAN FRANCISCO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LOPINAVIR PLUS RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAZIL; DRUG INDUSTRY; DRUG MANUFACTURE; HEALTH PROGRAM; INFECTION PREVENTION; LICENSING; PATENT; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; BRAZIL; COMMERCE; HUMANS; LEGISLATION, DRUG; LICENSURE; PATENTS;

EID: 27144533242     PISSN: 1064590X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)